Overview

Efficacy of Vitamin D Supplementation in Multiple Sclerosis (EVIDIMS)

Status:
Terminated
Trial end date:
2017-06-01
Target enrollment:
Participant gender:
Summary
Examination of efficacy, safety and tolerability of vitamin D3 in the treatment of Multiple Sclerosis (MS).
Phase:
Phase 2
Details
Lead Sponsor:
Charite University, Berlin, Germany
Collaborators:
NeuroCure Clinical Research Center
NeuroCure Clinical Research Center, Charite, Berlin
Treatments:
Ergocalciferols
Vitamin D
Vitamins